Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 6;9(1):e82622.
doi: 10.1371/journal.pone.0082622. eCollection 2014.

Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole

Collaborators, Affiliations

Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole

Patrick M Chong et al. PLoS One. .

Abstract

Background: Clostridium difficile is an anaerobic, Gram-positive bacterium that has been implicated as the leading cause of antibiotic-associated diarrhea. Metronidazole is currently the first-line treatment for mild to moderate C. difficile infections. Our laboratory isolated a strain of C. difficile with a stable resistance phenotype to metronidazole. A shotgun proteomics approach was used to compare differences in the proteomes of metronidazole-resistant and -susceptible isolates.

Methodology/principal findings: NAP1 C. difficile strains CD26A54_R (Met-resistant), CD26A54_S (reduced- susceptibility), and VLOO13 (Met-susceptible) were grown to mid-log phase, and spiked with metronidazole at concentrations 2 doubling dilutions below the MIC. Peptides from each sample were labeled with iTRAQ and subjected to 2D-LC-MS/MS analysis. In the absence of metronidazole, higher expression was observed of some proteins in C. difficile strains CD26A54_S and CD26A54_R that may be involved with reduced susceptibility or resistance to metronidazole, including DNA repair proteins, putative nitroreductases, and the ferric uptake regulator (Fur). After treatment with metronidazole, moderate increases were seen in the expression of stress-related proteins in all strains. A moderate increase was also observed in the expression of the DNA repair protein RecA in CD26A54_R.

Conclusions/significance: This study provided an in-depth proteomic analysis of a stable, metronidazole-resistant C. difficile isolate. The results suggested that a multi-factorial response may be associated with high level metronidazole-resistance in C. difficile, including the possible roles of altered iron metabolism and/or DNA repair.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Work flow for digestion and analysis of iTRAQ-labeled peptides from NAP1 C. difficile strains.
Met, metronidazole. See text for details.
Figure 2
Figure 2. Hierarchical clustering analysis of protein expression using Perseus (Max Quant, v1.1.1.34). V
(VLOO13). VM (VLOO13+Met). R (CD26A54_R). RM (CD26A54_R+Met). S (CD26A54_S). SM (CD26A54_S+Met). Green, reduced expression relative to VLOO13. Red, increased expression relative to VLOO13. Black, no difference in expression. White, no data. Number refers to experiment #. a, CD26A54_S set. b, CD26A54_R set.

References

    1. Kyne L, Hamel MB, Polavaram R, Kelly CP (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile . Clin Infect Dis 34: 346–353. - PubMed
    1. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18: 247–263. - PMC - PubMed
    1. Delaney JAC, Dial S, Barkun A, Suissa S (2007) Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis 13: 761–763. - PMC - PubMed
    1. O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic B1/NAP1/027 strain. Gastroenterology 136: 1913–1924. - PubMed
    1. Leffler DA, Lamont JT (2009) Treatment of Clostridium difficile-associated disease. Gastroenterology 136: 1899–1912. - PubMed

MeSH terms